Related Experiment Video
Updated: Jan 7, 2026

09:37
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.1K
Tumors With GNAQ Mutations: A Review With a Focus on Possible Shared Neural Crest Origins
1Histopathologist, Department of Cellular Pathology, Hospital El Bierzo, Ponferrada, Spain.
The American Journal of Dermatopathology
|December 29, 2025
Summary
Mutations in the guanosine nucleotide-binding protein Q gene (GNAQ) cause diverse vascular and melanocytic pathologies. This is explained by the neural crest
Area of Science:
- Developmental Biology
- Genetics
- Dermatopathology
Background:
- Guanylate-binding protein Q gene (GNAQ) mutations are linked to complex pathologies with vascular and melanocytic features.
- Traditional understanding separates melanocyte (neural crest) and blood vessel (mesodermal) origins.
- Recent discoveries highlight ectomesenchyme, a neural crest derivative, contributing to trunk structures.
Purpose of the Study:
- To review GNAQ mutation-associated dermatopathology.
- To integrate these findings within the concept of ectomesenchyme.
- To explain how GNAQ mutations influence diverse pathologies and challenge traditional cell origin theories.
Main Methods:
- Review of pathological entities associated with GNAQ mutations in dermatopathology.
- Analysis of GNAQ's role in ectomesenchyme development.
- Integration of genetic findings with developmental biology principles.
Main Results:
- GNAQ mutations can lead to a spectrum of dermatological lesions.
- Neural crest cells, via ectomesenchyme, can differentiate into both melanocytic and vascular components.
- This provides a unified ontogenetic explanation for GNAQ-related pathologies.
Conclusions:
- GNAQ mutations underscore the plasticity of neural crest derivatives.
- Ectomesenchyme provides a framework for understanding shared origins of vascular and melanocytic cells.
- This challenges established distinctions between melanocytes and endothelial cells.
More Related Videos
Related Concept Videos
Determination
20.6K
During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In...
20.6K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K

